Changes in markers of hepatic steatosis and fibrosis in patients with type 2 diabetes during treatment with glucagon-like peptide-1 receptor agonists. A multicenter retrospective longitudinal study.
暂无分享,去创建一个
A. Avogaro | G. Fadini | G. Targher | A. Lapolla | M. Morieri | M. Rigato | V. Frison | N. Simioni | M. D’Ambrosio | F. Tadiotto | A. Paccagnella